Kazuo Kobayashi

7PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2026
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

|Nov 05, 2025
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC.

Kazuo Kobayashi, Takeru Wakatsuki, Erika Sugiyama

|Nov 16, 2023
Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.

Yoshikazu Tateai, Kazuyoshi Kawakami, Minori Teramae

|Sep 07, 2023
Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study.

Takashi Yokokawa, Kenichi Suzuki, Daiki Tsuji

|Feb 26, 2021
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers.

Kazuo Kobayashi, Erika Sugiyama, Eiji Shinozaki

|Jan 22, 2020
Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer-a retrospective study.

Takeshi Aoyama, Takashi Tsunoda, Hiroki Kato

Pageof 2

Frequent Collaborators

7 joint publications

Kazuyoshi Kawakami

4 joint publications

Takeshi Aoyama

4 joint publications

Takashi Yokokawa

2 joint publications

Daiki Tsuji